RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 1 filers reported holding RA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $22,133,000 | +22.2% | 461,016 | +19.4% | 3.12% | +520.9% |
| Q4 2019 | $18,114,000 | +902.4% | 385,978 | +378.4% | 0.50% | +1187.2% |
| Q1 2019 | $1,807,000 | -8.6% | 80,681 | -25.7% | 0.04% | -23.5% |
| Q4 2018 | $1,976,000 | +19.4% | 108,592 | +19.1% | 0.05% | +45.7% |
| Q3 2018 | $1,655,000 | +352.2% | 91,174 | +149.4% | 0.04% | +400.0% |
| Q2 2018 | $366,000 | -54.4% | 36,557 | -75.8% | 0.01% | -58.8% |
| Q1 2018 | $802,000 | +62.7% | 150,951 | +160.2% | 0.02% | +54.5% |
| Q4 2017 | $493,000 | -51.2% | 58,005 | -15.2% | 0.01% | -42.1% |
| Q3 2017 | $1,011,000 | -19.9% | 68,426 | +1.6% | 0.02% | -24.0% |
| Q2 2017 | $1,262,000 | – | 67,338 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,851,808 | $20,453,000 | 1.57% |
| NEA Management Company, LLC | 5,493,636 | $29,171,000 | 1.30% |
| Foresite Capital Management IV, LLC | 450,000 | $2,390,000 | 0.99% |
| Novo Holdings A/S | 1,465,838 | $7,784,000 | 0.98% |
| Consonance Capital Management LP | 1,454,761 | $7,725,000 | 0.71% |
| VHCP Management II, LLC | 544,612 | $2,892,000 | 0.70% |
| ACUTA CAPITAL PARTNERS, LLC | 270,000 | $1,434,000 | 0.23% |
| Athanor Capital, LP | 67,150 | $357,000 | 0.16% |
| Rock Springs Capital Management LP | 600,000 | $3,186,000 | 0.14% |
| Eventide Asset Management | 388,000 | $2,060,000 | 0.10% |